Platz KP et al. |
Causes of death following liver transplantation in FK 506- and cyclosporine-treated patients. |
1994 |
Transplant. Proc. |
pmid:7527952
|
Felldin M et al. |
Rescue therapy with Tacrolimus (FK506) in renal transplant recipients--a multicenter analysis. |
1995 |
Transplant. Proc. |
pmid:8540032
|
Masutani K et al. |
Protocol biopsy findings in living donor kidney transplant patients treated with once-daily or twice-daily tacrolimus formulation. |
2014 |
Transplant. Proc. |
pmid:24655972
|
Kahan BD |
Cyclosporine: the base for immunosuppressive therapy--present and future. |
1993 |
Transplant. Proc. |
pmid:7679819
|
Tze WJ et al. |
Prolongation of pig islet xenograft survival in rats by local immunosuppression with FK 506. |
1994 |
Transplant. Proc. |
pmid:7513471
|
Zeevi A et al. |
Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA. |
1990 |
Transplant. Proc. |
pmid:1689884
|
Yabuuchi H et al. |
Prominent prolongation of islet xenograft survival in combination therapy with FK 506 and 15-deoxyspergualin. |
1991 |
Transplant. Proc. |
pmid:1703718
|
Morris RE et al. |
Comparative immunopharmacologic effects of FK 506 and CyA in in vivo models of organ transplantation. |
1990 |
Transplant. Proc. |
pmid:1689885
|
Spinelli GA et al. |
Lipid profile changes during the first year after kidney transplantation: risk factors and influence of the immunosuppressive drug regimen. |
2011 |
Transplant. Proc. |
pmid:22172836
|
Soda M et al. |
Association Between Tacrolimus Pharmacokinetics and Cytochrome P450 3A5 and Multidrug Resistance Protein 1 Exon 21 Polymorphisms. |
|
Transplant. Proc. |
pmid:28736028
|
Mac Guad R et al. |
Effects of CYP3A5 Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients. |
|
Transplant. Proc. |
pmid:26915847
|
Herrero JC et al. |
Role of immunosuppressive treatments based on mycophenolate mofetil in posttransplantation renal surgical complications. |
2002 |
Transplant. Proc. |
pmid:11959201
|
Facundo C et al. |
Results of a triple induction regime with tacrolimus, mycophenolate mofetil, and prednisone in renal transplantation. |
2002 |
Transplant. Proc. |
pmid:11959203
|
McDiarmid S et al. |
One hundred children treated with tacrolimus after primary orthotopic liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636564
|
Fraile P et al. |
Non-skin solid tumors as a cause of morbidity and mortality after liver transplantation. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715943
|
Lauro A et al. |
Results of intestinal and multivisceral transplantation in adult patients: Italian experience. |
2006 Jul-Aug |
Transplant. Proc. |
pmid:16908252
|
Ueno T et al. |
Renal dysfunction following adult intestinal transplant under tacrolimus-based immunosuppression. |
2006 Jul-Aug |
Transplant. Proc. |
pmid:16908274
|
Oltean M et al. |
Transplantation of preconditioned intestinal grafts is associated with lower inflammatory activation and remote organ injury in rats. |
2006 Jul-Aug |
Transplant. Proc. |
pmid:16908278
|
Burkhalter F et al. |
High incidence of rejection episodes and poor tolerance of sirolimus in a protocol with early steroid withdrawal and calcineurin inhibitor-free maintenance therapy in renal transplantation: experiences of a randomized prospective single-center study. |
2012 |
Transplant. Proc. |
pmid:23195006
|
Luk JM et al. |
Immunosuppressive effects of Tripterygium wilfordii polysaccharide on LPS-stimulated human monocytes. |
2000 |
Transplant. Proc. |
pmid:11120045
|
Bora F et al. |
Drug interaction between tacrolimus and ertapenem in renal transplantation recipients. |
2012 |
Transplant. Proc. |
pmid:23195020
|
Abu-Elmagd KM et al. |
Monitoring and treatment of intestinal allograft rejection in humans. |
1993 |
Transplant. Proc. |
pmid:7680150
|
Charco R et al. |
Steroids and living liver donation increase tacrolimus blood levels in living donor liver transplantation. |
2005 |
Transplant. Proc. |
pmid:16386588
|
Mayer AD |
Four-year follow-up of the European Tacrolimus Multicenter Renal Study. |
1999 |
Transplant. Proc. |
pmid:10576038
|
Crespo-Leiro MG |
Calcineurin inhibitors in heart transplantation. |
2005 |
Transplant. Proc. |
pmid:16386614
|
Farghali H et al. |
A biochemical and 31P-NMR investigation of the effect of FK 506 and cyclosporine pretreatment on immobilized hepatocytes perifused with ethanol. |
1991 |
Transplant. Proc. |
pmid:1721284
|
Harrison DM et al. |
Reduction in hospital stay after liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623451
|
Nishikawa S et al. |
Extended mycophenolate mofetil administration beyond day 30 in allogeneic hematopoietic stem cell transplantation as preemptive therapy for severe graft-versus-host disease. |
2009 |
Transplant. Proc. |
pmid:19917404
|
Sathyan S et al. |
A case of recurrent immunotactoid glomerulopathy in an allograft treated with rituximab. |
2009 |
Transplant. Proc. |
pmid:19917422
|
Schulz T et al. |
Tacrolimus/mycophenolate mofetil/steroid-based immunosuppression after pancreas-kidney transplantation with single shot antithymocyte globulin. |
1998 |
Transplant. Proc. |
pmid:9636623
|
Pérez-Flores I et al. |
Incidence and risk factors for the metabolic syndrome and posttransplant diabetes in renal transplant recipients taking tacrolimus. |
2010 |
Transplant. Proc. |
pmid:20970565
|
Marzoa-Rivas R et al. |
Conversion of heart transplant patients from standard to sustained-release tacrolimus requires a dosage increase. |
2010 |
Transplant. Proc. |
pmid:20970591
|
Marzorati S et al. |
Effects of systemic immunosuppression on islet engraftment and function into a subcutaneous biocompatible device. |
2009 Jan-Feb |
Transplant. Proc. |
pmid:19249555
|
Lodewijk L et al. |
Effect of liver regeneration on the pharmacokinetics of immunosuppressive drugs. |
2009 Jan-Feb |
Transplant. Proc. |
pmid:19249561
|
Nardo B et al. |
Pretransplant xenogeneic blood transfusion combined with FK 506 prolongs hamster-to-rat liver xenograft survival. |
1994 |
Transplant. Proc. |
pmid:7518112
|
Pan F et al. |
FK 506 prolongs survival of liver but not heart mouse-to-rat vascularized xenografts. |
1994 |
Transplant. Proc. |
pmid:7518113
|
Florman S et al. |
Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen. |
2005 |
Transplant. Proc. |
pmid:15848672
|
Wiesner RH et al. |
Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection. |
1993 |
Transplant. Proc. |
pmid:7682352
|
Bäckman L et al. |
Whole-blood and plasma levels of FK 506 after liver transplantation: results from the US Multicenter Trial. FK506 Multicenter Study Group. |
1995 |
Transplant. Proc. |
pmid:7533361
|
Frank B et al. |
Neurotoxicity of FK 506 in liver transplant recipients. |
1993 |
Transplant. Proc. |
pmid:7682355
|
Söderdahl G et al. |
FK 506 improves recovery of bile secretion following orthotopic liver transplantation in man. |
1995 |
Transplant. Proc. |
pmid:7533362
|
Zeevi A et al. |
Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin. |
1991 |
Transplant. Proc. |
pmid:1721315
|
Matsuura T et al. |
Beneficial immunosuppressive effect of combined use of FK 506 and cyclosporine assessed by proliferative responses of cloned human T cells. |
1991 |
Transplant. Proc. |
pmid:1721316
|
Chen J et al. |
Observation of efficacy and safety of converting the calcineurin inhibitor to sirolimus in renal transplant recipients with chronic allograft nephropathy. |
2008 |
Transplant. Proc. |
pmid:18589119
|
Wynn C et al. |
High level of TGF-beta in organ transplantation might be due to rejection rather than calcineurin inhibitor medication. |
2002 |
Transplant. Proc. |
pmid:12176408
|
Marcén R et al. |
Conversion from cyclosporine microemulsion to tacrolimus in stable kidney transplant patients with hypercholesterolemia is related to an improvement in cardiovascular risk profile: a prospective study. |
2006 |
Transplant. Proc. |
pmid:17097957
|
Mortensen DM et al. |
Calcineurin activity in tacrolimus-treated renal transplant patients early after and 5 years after transplantation. |
2006 |
Transplant. Proc. |
pmid:17098028
|
Borrows R et al. |
Steroid sparing in renal transplantation with tacrolimus and mycophenolate mofetil: three-year results. |
2005 |
Transplant. Proc. |
pmid:15919468
|
Loucaidou M et al. |
Late steroid withdrawal for renal transplant recipients on tacrolimus and MMF is safe. |
2005 |
Transplant. Proc. |
pmid:15919469
|
Ochiai T et al. |
Japanese multicenter studies of FK 506 in renal transplantation. Japanese FK 506 Study Group. |
1995 |
Transplant. Proc. |
pmid:7533419
|
Takaya S et al. |
Retransplantation of liver: a comparison of FK 506- and cyclosporine-treated patients. |
1991 |
Transplant. Proc. |
pmid:1721348
|
Rabkin JM et al. |
Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176483
|
Langrehr JM et al. |
First results from a prospective randomized trial comparing steroid-free induction therapy with tacrolimus and MMF versus tacrolimus and steroids in patients after liver transplantation for HCV. |
2002 |
Transplant. Proc. |
pmid:12176487
|
Lyne JC et al. |
Cadaveric renal transplantation against a positive historic crossmatch under tacrolimus immunosuppression: long-term follow-up. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123015
|
Zucker K et al. |
Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123027
|
Iaria G et al. |
Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation. |
2011 |
Transplant. Proc. |
pmid:21620043
|
Sugitani A et al. |
Intestinal neurons in acute and chronic rejection after small bowel transplantation in dogs. |
1996 |
Transplant. Proc. |
pmid:8907941
|
Ronchetti F et al. |
Mucosal hyaluronic acid quantification in small bowel transplantation in pigs. |
1996 |
Transplant. Proc. |
pmid:8907950
|
Takahara S et al. |
Monitoring of FK 506 blood levels in kidney transplant recipients. |
1994 |
Transplant. Proc. |
pmid:7520623
|
Sun CK et al. |
Intensive care after orthotopic liver transplantation. |
1994 |
Transplant. Proc. |
pmid:7520627
|
Yin DP et al. |
Efficacy of FK506, leflunomide, anti-CD4, and CTLA4IG treatments in rat to mouse pancreas xenograft transplantation. |
2000 |
Transplant. Proc. |
pmid:10936320
|
Prasad SJ et al. |
In vitro effects of cyclosporine and FK 506 on the renal cortex. |
1991 |
Transplant. Proc. |
pmid:1721380
|
Witzigmann H et al. |
Immunosuppression with sirolimus/tacrolimus combination in pancreas transplantation: 1-year results. |
2002 |
Transplant. Proc. |
pmid:12493472
|
Kusne S et al. |
Early infections in kidney transplant recipients under FK 506. |
1991 |
Transplant. Proc. |
pmid:1703364
|
Citterio F et al. |
Conversion to tacrolimus immunosuppression in renal transplant recipients: 12-month follow-up. |
2002 |
Transplant. Proc. |
pmid:12176535
|
Terakura M et al. |
Effects of peritransplant administration of hematopoietic growth factors on the development of chronic allograft rejection. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083380
|
Kim JD et al. |
Single-Center Experience of ABO-Incompatible Living-Donor Liver Transplantation With a New Simplified Intravenous Immunoglobulin Protocol: A Propensity Score-Matching Analysis. |
2016 |
Transplant. Proc. |
pmid:27320573
|
Hariharan S et al. |
Long-term renal and pancreas function with tacrolimus rescue therapy following kidney/pancreas transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123462
|
Jonas S et al. |
Posttransplant malignancy and newer immunosuppressive protocols after liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8962257
|
Alessiani M et al. |
Pharmacokinetic study of intraarterial local intestinal infusion of tacrolimus. |
2000 |
Transplant. Proc. |
pmid:10995915
|
Madariaga JR et al. |
The long-term efficacy of multivisceral transplantation. |
2000 |
Transplant. Proc. |
pmid:10995918
|
Ricordi C et al. |
Human islet allotransplantation under FK 506. |
1991 |
Transplant. Proc. |
pmid:1721410
|
Tze WJ et al. |
Long-term survival of islet allografts in diabetic rats treated with FK 506. |
1991 |
Transplant. Proc. |
pmid:1721411
|
Shinozuka N et al. |
Correlation between simplified immunocompetence assay and clinical graft states in kidney or liver transplant recipients. |
1996 |
Transplant. Proc. |
pmid:8658649
|
Beck Y and Akiyama N |
Effect of FK-506 and cyclosporine on human lymphocyte responses in vitro. |
1989 |
Transplant. Proc. |
pmid:2472695
|
Wang X et al. |
Intraportal FK 506 improves intrahepatic islet allograft survival. |
1991 |
Transplant. Proc. |
pmid:1721412
|
McCarter JF et al. |
FK 506 protects brain tissue in animal models of stroke. |
2001 |
Transplant. Proc. |
pmid:11377571
|
Baran DA et al. |
Predictors of early renal insufficiency in cardiac transplant recipients initiated on tacrolimus. |
2002 |
Transplant. Proc. |
pmid:12176609
|
Zhou S et al. |
Tacrolimus enhances the invasion potential of hepatocellular carcinoma cells and promotes lymphatic metastasis in a rat model of hepatocellular carcinoma: involvement of vascular endothelial growth factor-C. |
2011 |
Transplant. Proc. |
pmid:21911157
|
Kauffman HM et al. |
Drug regimens affect cadaveric kidney graft survival. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267176
|
Hummel AD et al. |
Application of artificial neural networks in renal transplantation: classification of nephrotoxicity and acute cellular rejection episodes. |
2010 |
Transplant. Proc. |
pmid:20304167
|
Ettenger RB |
New immunosuppressive agents in pediatric renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9723350
|
Li ZY et al. |
Analytical performance of the Abbott Architect i2000 tacrolimus assay in Chinese patients after renal transplantation. |
2010 |
Transplant. Proc. |
pmid:21168731
|
Grabczewska Z et al. |
Neither cyclosporine nor tacrolimus deteriorate endothelial function in renal transplant recipients assessed with reactive hyperernia index. |
2013 |
Transplant. Proc. |
pmid:23726621
|
Renner FC et al. |
The risk of polyomavirus-associated graft nephropathy is increased by a combined suppression of CD8 and CD4 cell-dependent immune effects. |
2013 |
Transplant. Proc. |
pmid:23726630
|
Hasegawa S et al. |
FK 506 and cyclosporine: effects and side effects in canine lung transplantation. |
1991 |
Transplant. Proc. |
pmid:1721443
|
Groth CG et al. |
New immunosuppressive drugs in transplantation. |
1993 |
Transplant. Proc. |
pmid:7689274
|
Thiru S et al. |
Pathological studies in canine and baboon renal allograft recipients immunosuppressed with FK-506. |
1987 |
Transplant. Proc. |
pmid:2445086
|
van den Berg AP et al. |
Recurrent HCV infection reduces the requirement for tacrolimus after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267375
|
Chávez R et al. |
Hepatotrophic effect of cyclosporine and FK 506 is not mimicked by rapamycin. |
1999 |
Transplant. Proc. |
pmid:10500655
|
EscartÃn A et al. |
Orthotopic small bowel transplantation in pigs without steroids. |
1999 |
Transplant. Proc. |
pmid:10500720
|
Ginevri F et al. |
Expression of collagen by renal fibroblasts treated with FK 506 in vitro. |
1998 |
Transplant. Proc. |
pmid:9636387
|
Hutchinson IV et al. |
Differences in the mode of action of cyclosporine and FK 506. |
1998 |
Transplant. Proc. |
pmid:9636388
|
Konno O et al. |
Early Outcomes of Living-Donor Kidney Transplantation With Immunosuppression Therapy Induction With Tacrolimus Extended-Release: A Comparison With Cyclosporine. |
2018 |
Transplant. Proc. |
pmid:30316378
|
Lautenschlager I et al. |
Efficiency of FK 506 and CyA to prevent acute cellular rejection of pig liver allografts. |
1991 |
Transplant. Proc. |
pmid:1714650
|
Suarez Benjumea A et al. |
Hepatitis C Virus in Kidney Transplant Recipients: A Problem on the Path to Eradication. |
2016 |
Transplant. Proc. |
pmid:27932111
|
Rodriguez Cubillo B et al. |
Risk Factors of Recurrence of Diabetic Nephropathy in Renal Transplants. |
2016 |
Transplant. Proc. |
pmid:27932117
|
Rathi M et al. |
Conversion from tacrolimus to cyclosporine in patients with new-onset diabetes after renal transplant: an open-label randomized prospective pilot study. |
2015 |
Transplant. Proc. |
pmid:26036543
|
Mohsin N et al. |
Pharmacokinetics of mycophenolate mofetil in Omani patients on cyclosporine or tacrolimus. |
2015 |
Transplant. Proc. |
pmid:26036534
|
Budde K et al. |
Tacrolimus rescue therapy in late rejection after renal transplantation: outcome after 18 months. |
1998 |
Transplant. Proc. |
pmid:9636503
|